ArticleCancer medicine2026

Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer.

Keiso Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.